Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
130 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01453179 | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)(LEIDA 2) | completed | Phase 4 | 221 | MEDA Pharma GmbH & Co. KGINDUSTRY | 2 | Feb 7, 2022 | clinicaltrials |
| NCT03220178 | Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy(PRECYCLE) | terminated | Phase 4 | 532 | Palleos Healthcare GmbHINDUSTRY | 1 |
| Jan 6, 2022 |
| clinicaltrials |
| NCT03735758 | Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib(PazoQoL) | terminated | Phase 4 | 11 | GWT-TUD GmbHOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02812992 | Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients(GrantPax) | completed | Phase 4 | 32 | AIO-Studien-gGmbHOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT01990534 | A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma | completed | Phase 4 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 7 | Apr 9, 2021 | clinicaltrials |
| NCT03511326 | PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK(SESAME 2) | completed | Phase 4 | 50 | Galderma R&DINDUSTRY | 1 | Feb 18, 2021 | clinicaltrials |
| NCT00380874 | Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer | terminated | Phase 4 | 64 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc.INDUSTRY | 6 | Feb 11, 2021 | clinicaltrials |
| NCT01739764 | An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol | completed | Phase 4 | 215 | Hoffmann-La RocheINDUSTRY | 25 | Jan 7, 2021 | clinicaltrials |
| NCT02736760 | Daylight-PDT With MAL for AK and Photodamaged Skin | completed | Phase 4 | 58 | University Hospital RegensburgOTHER | 1 | Nov 9, 2020 | clinicaltrials |
| NCT01588184 | An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study | completed | Phase 4 | 95 | Hoffmann-La RocheINDUSTRY | 21 | Nov 5, 2020 | clinicaltrials |
| NCT00510354 | Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate(Radix) | completed | Phase 4 | 28 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 10, 2020 | clinicaltrials |
| NCT01243489 | Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation(Crescendo) | completed | Phase 4 | 104 | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHOTHER | 1 | Dec 20, 2019 | clinicaltrials |
| NCT01578213 | Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients(ISAV) | completed | Phase 4 | 112 | University of Milano BicoccaOTHER | 5 | Dec 3, 2019 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT02500641 | Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout(FORWARD) | completed | Phase 4 | 196 | Menarini International Operations Luxembourg SAINDUSTRY | 6 | Jun 21, 2019 | clinicaltrials |
| NCT01180049 | Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma | completed | Phase 4 | 101 | PfizerINDUSTRY | 11 | May 20, 2019 | clinicaltrials |
| NCT01266837 | Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)(MARC-2) | completed | Phase 4 | 64 | iOMEDICO AGINDUSTRY | 1 | Nov 14, 2017 | clinicaltrials |
| NCT02248571 | Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab(IMPROVE) | completed | Phase 4 | 85 | iOMEDICO AGINDUSTRY | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01521715 | First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma(FLIPPER) | completed | Phase 4 | 44 | iOMEDICO AGINDUSTRY | 1 | Aug 23, 2017 | clinicaltrials |
| NCT00430352 | MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. | completed | Phase 4 | 545 | Hoffmann-La RocheINDUSTRY | 24 | Aug 14, 2017 | clinicaltrials |
| NCT01514448 | Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib | completed | Phase 4 | 29 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 19, 2017 | clinicaltrials |
| NCT01639703 | Hepatic Xenetix-CT Perfusion | completed | Phase 4 | 96 | GuerbetINDUSTRY | 4 | Jul 13, 2017 | clinicaltrials |
| NCT00375752 | Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer(FEMZONE) | terminated | Phase 4 | 168 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00171964 | Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions | completed | Phase 4 | 75 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 1, 2017 | clinicaltrials |
| NCT00176046 | Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study | completed | Phase 4 | 114 | Heidelberg UniversityOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00329602 | Long-term Study Of Ropinirole In Restless Legs Syndrome | completed | Phase 4 | 404 | GlaxoSmithKlineINDUSTRY | 11 | Mar 23, 2017 | clinicaltrials |
| NCT00376064 | Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly | completed | Phase 4 | 20 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 6, 2017 | clinicaltrials |
| NCT01061177 | Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase('MACS1252) | completed | Phase 4 | 1,090 | Novartis PharmaceuticalsINDUSTRY | 26 | Feb 24, 2017 | clinicaltrials |
| NCT00535652 | Concentration of Ertapenem in Colorectal Tissue | completed | Phase 4 | 23 | University of UlmOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT02379000 | TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy | unknown | Phase 4 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00372476 | Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer(INV181) | completed | Phase 4 | 33 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01660906 | Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib | completed | Phase 4 | 39 | Bristol-Myers SquibbINDUSTRY | 5 | Nov 22, 2016 | clinicaltrials |
| NCT00172003 | Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis | completed | Phase 4 | 50 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00391690 | Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | completed | Phase 4 | 99 | NovartisINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT01935531 | Effects of Topical Diclofenac on Tumor Metabolism | completed | Phase 4 | 38 | University Hospital RegensburgOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01317615 | RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation | completed | Phase 4 | 49 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 30, 2016 | clinicaltrials |
| NCT01424839 | Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors(SIOPCNSGCTII) | unknown | Phase 4 | 400 | University Hospital MuensterOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01950871 | Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning(PHSTT-01) | terminated | Phase 4 | 80 | Advanced Medical Diagnostics s.a.INDUSTRY | 18 | Jan 5, 2015 | clinicaltrials |
| NCT00333229 | A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss | terminated | Phase 4 | 11 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 25, 2014 | clinicaltrials |
| NCT00764621 | Health Economic Evaluation of Primovist-enhanced Liver MRI | completed | Phase 4 | 360 | BayerINDUSTRY | 9 | Nov 4, 2014 | clinicaltrials |
| NCT02186886 | Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab | unknown | Phase 4 | 50 | Kliniken im Naturpark AltmuehltalOTHER | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01315990 | FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema(DERMATUX) | unknown | Phase 4 | 165 | Dr. Carl SchimanskiOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT01908556 | Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)(PreFace) | unknown | Phase 4 | 3,545 | Institut fuer FrauengesundheitOTHER | 1 | Jul 25, 2013 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials